← Back to All Filings

FLGT CSO Sells $39K in Stock to Cover Taxes on Vested RSUs

Low SignificanceOctober 28, 2025 at 5:32:59 PM EDT

Fulgent Genetics, Inc.

$FLGT4CIK: 0001674930

Subscribe to track FLGT

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

FLGT CSO Sells $39K in Stock to Cover Taxes on Vested RSUs

Company: Fulgent Genetics, Inc. (FLGT) Form: 4 | Filed: 2025-10-28 Significance: Low

Insider: Gao Hanlin Title: Chief Scientific Officer | Relationship: Officer

Transaction: • Type: Tax Withholding • Shares: 1,642 • Price: $23.74 • Value: $38,981 • Owned After: 955,443

Key Insight: This was a non-discretionary sale (Code 'F') to cover tax obligations from vesting RSUs, not a change in the insider's outlook. The CSO retains a significant stake of over 955k shares.

Market Context: The transaction represents a negligible 0.005% of the company's $0.71B market cap, indicating it is immaterial to the market.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Fulgent Genetics, Inc. (FLGT)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Scientific Officer executed a routine, non-discretionary sale of stock solely to cover tax liabilities on vesting Restricted Stock Units (RSUs).
  • Market Impact: Negligible. This type of transaction does not signal a change in insider sentiment and is too small to affect the market.

Company Information

FieldValue
CompanyFulgent Genetics, Inc.
Ticker SymbolFLGT
CIK0001674930
IndustrySERVICES-MEDICAL LABORATORIES

Insider Information

FieldValue
NameGao Hanlin
CIK0001684532
Title/PositionChief Scientific Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-26
Transaction CodeF - Withholding of securities to satisfy tax liabilities
Security TypeCommon Stock
Shares Involved1,642
Price Per Share$23.74
Total Value$38,980.68
Shares Owned After955,443
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$38,980.68
% of Market Cap0.0055%
Shares Transacted1,642
% of Shares Outstanding0.0054%
Post-Transaction Ownership955,443 shares (3.12% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value of ~$39k is an insignificant fraction of Fulgent Genetics' $710 million market capitalization.
  • Ownership Concentration: The sale is minor compared to the insider's remaining holdings. The CSO still owns over 3.1% of the company's total shares outstanding, a substantial position indicating continued alignment with shareholder interests.
  • Dilution Impact: Not applicable, as this was a disposition of already-owned shares, not an issuance of new equity.
  • Transaction Significance: The transaction is classified as having low significance. Both its value relative to market cap and the number of shares relative to shares outstanding fall well below the lowest materiality thresholds. The nature of the transaction (tax withholding) further reduces its informational value.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The market typically ignores 'F' code transactions as they are automated, non-discretionary, and do not reflect an insider's investment decision or sentiment about the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction is too small to have a noticeable effect on trading volume.
  • Sentiment Indicator: Neutral. This filing provides no new information to influence bullish or bearish sentiment.

Investment Insights

Positive Market Indicators

  • The insider maintains a significant ownership stake of over 3% in the company post-transaction.

Risk Factors

  • No risk factors are indicated by this filing.

Key Takeaways

  1. Routine Transaction: This is a standard "sell-to-cover" transaction to handle tax obligations from equity compensation.
  2. No Change in Sentiment: The sale should not be interpreted as the insider losing confidence in the company.
  3. Immaterial Size: The transaction's value and share count are negligible compared to the company's market cap and total shares, making it a non-event for investors.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote explicitly states the shares were withheld to satisfy tax withholding obligations that arose upon the vesting of restricted stock units. This confirms the non-discretionary nature of the disposition.
Topics:#SECFiling#InsiderTrading#FLGT#FulgentGenetics#Form4#StockMarket#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.